title: Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.
abstract: Colon tumors frequently harbor mutation in K-RAS and/or N-RAS, members of a GTPase family operating as a central hub for multiple key signaling pathways. While these proteins are strongly homologous, they exhibit diverse downstream effects on cell behavior. Utilizing an isogenic panel of human colon carcinoma cells bearing oncogenic mutations in K-RAS and/or N-RAS, we observed that K-RAS and double mutants similarly yield elevated apoptosis in response to treatment with TNFalpha compared to N-RAS mutants. Regardless, and in surprising contrast, key phospho-protein signals were more similar between N-RAS and dual mutants. This apparent contradiction could not be explained by any of the key signals individually, but a multi-pathway model constructed from the single-mutant cell line data was able to predict the behavior of the dual-mutant cell line. This success arises from a quantitative integration of multiple pro-apoptotic (pIkappaBalpha, pERK2) and pro-survival (pJNK, pHSP27) signals in manner not easily discerned from intuitive inspection.
authors.affiliation: Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, 16-343, Cambridge, MA 02139, USA.
authors.forename: Pamela K
authors.initials: PK
authors.lastname: Kreeger
authors.forename: Yufang
authors.initials: Y
authors.lastname: Wang
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Haigis
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Lauffenburger
mesh_terms: D002460:Cell Line; D003106:Colon / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D016207:Cytokines / Q000187:drug effects / Q000276:immunology*; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D009154:Mutation; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*; D018631:ras Proteins / Q000235:genetics / Q000276:immunology*
chemical_list: D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D018631:ras Proteins
references.citation: Cell. 2006 Mar 24;124(6):1225-39
references.pmid: 16564013
references.citation: Nat Rev Cancer. 2003 Jan;3(1):11-22
references.pmid: 12509763
references.citation: Nature. 2009 Nov 5;462(7269):44-5
references.pmid: 19890318
references.citation: Mol Syst Biol. 2007;3:150
references.pmid: 18059445
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1569-90
references.pmid: 16030008
references.citation: Curr Colorectal Cancer Rep. 2009 Apr 1;5(2):69-74
references.pmid: 19756239
references.citation: Nature. 1987 May 28-Jun 3;327(6120):298-303
references.pmid: 2438556
references.citation: Cancer Res. 2009 Oct 15;69(20):8191-9
references.pmid: 19789336
references.citation: Nat Rev Cancer. 2003 Jun;3(6):459-65
references.pmid: 12778136
references.citation: Oncogene. 2007 May 10;26(21):3051-9
references.pmid: 17130841
references.citation: Mol Cell Biol. 2002 Mar;22(5):1589-606
references.pmid: 11839824
references.citation: Gastroenterology. 1990 Aug;99(2):416-20
references.pmid: 2194896
references.citation: Science. 1993 Apr 2;260(5104):85-8
references.pmid: 8465203
references.citation: J Biol Chem. 2004 Aug 27;279(35):36680-8
references.pmid: 15213223
references.citation: Science. 2005 Dec 9;310(5754):1646-53
references.pmid: 16339439
references.citation: Nat Genet. 2008 May;40(5):600-8
references.pmid: 18372904
references.citation: Hepatology. 2008 Jul;48(1):276-88
references.pmid: 18536058
references.citation: PLoS Comput Biol. 2007 Jan 5;3(1):e4
references.pmid: 17206861